Rikinari Hanayama

6PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Structure and dynamics of materialsMedical molecular engineering of nucleic acids and proteinsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 17, 2026
Single-Vesicle Functional Nanophenotyping Reveals Heterogeneous PD-L1 Accessibility in Triple-Negative Breast Cancer.

|Mar 28, 2025
Direct delivery of immune modulators to tumour-infiltrating lymphocytes using engineered extracellular vesicles.

Xiabing Lyu, Tomoyoshi Yamano, Kanto Nagamori

|Aug 22, 2024
The Rubicon-WIPI axis regulates exosome biogenesis during ageing.

Kyosuke Yanagawa, Akiko Kuma, Maho Hamasaki

|Aug 07, 2024
Quality and Safety Considerations for Therapeutic Products Based on Extracellular Vesicles.

Yoshinobu Takakura, Rikinari Hanayama, Kazunari Akiyoshi

|Nov 30, 2020
Tumor-secreted proliferin-1 regulates adipogenesis and lipolysis in cachexia.

Tuan Duc Nguyen, Yuji Miyatake, Takeshi Yoshida

|Sep 15, 2020
Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer.

Rong Wang, Tadaaki Yamada, Kenji Kita

Pageof 1

Frequent Collaborators

2 joint publications

Tomoyoshi Yamano

1 joint publications

Rong Wang

1 joint publications

Tadaaki Yamada

1 joint publications

Kenji Kita